imatinib mesylate has been researched along with Cancer of Head in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (48.15) | 29.6817 |
| 2010's | 13 (48.15) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Bindal, P; Noor, A; Ramirez, M; Vredenburgh, J | 1 |
| Dębiec-Rychter, M; Jagielska, B; Klimczak, A; Pieńkowska-Grela, B; Rutkowski, P; Świtaj, T; Wągrodzki, M; Ługowska, I | 1 |
| Cordes, N; Dickreuter, E; Koppenhagen, P | 1 |
| Bologna, G; Cama, A; D'Argenio, A; Esposito, DL; Florio, R; Guarnieri, S; Lanuti, P; Lotti, LV; Marchisio, M; Mariani-Costantini, R; Morgano, A; Opocher, G; Pantalone, MR; Paties, CT; Perconti, S; Prasad, SC; Rajasekhar, VK; Rossi, C; Sanna, M; Schiavi, F; Sheu, A; Söderberg-Nauclér, C; Taschin, E; Tramontana, L; Verginelli, F; Veronese, A; Vespa, S; Visone, R | 1 |
| Aderhold, C; Faber, A; Hoermann, K; Hofheinz, RD; Sauter, A; Schultz, JD; Stern-Straeter, J; Umbreit, C | 1 |
| Bauer, S; Dimitrakopoulou-Strauss, A; Gruenwald, V; Haller, F; Hohenberger, P; Kasper, B; Limprecht, R; Pilz, L; Rauch, G; Reichardt, P; Sommer, M | 1 |
| Aguilera, J; Chen, JS; Chu, TS; Lopez, JP; Ongkeko, WM; Pardo, FS | 1 |
| Bran, B; Bran, G; Hörmann, K; Riedel, F | 1 |
| Anders, C; Erben, P; Faber, A; Hofheinz, RD; Hörmann, K; Riedel, F; Rotunno, S; Sauter, A; Schultz, JD; Sommer, JU; Thorn, C | 1 |
| Anders, C; Erben, P; Hofheinz, RD; Hörmann, K; Rotunno, S; Sauter, A; Schultz, JD; Sommer, JU; Stern-Straeter, J | 1 |
| O'Bryan, KW; Ratner, D | 1 |
| Erben, P; Faber, A; Hofheinz, RD; Hörmann, K; Mühlheim, K; Sauter, A; Schultz, JD; Sommer, JU; Thorn, C | 1 |
| Blumenschein, GR; Charnsangavej, C; Fossella, FV; Fujimoto, J; Hong, WK; Kies, MS; Lee, JJ; Liu, S; Marom, EM; Papadimitrakopoulou, V; Stewart, DJ; Tran, HT; Tsao, AS; Wistuba, II | 1 |
| Erben, P; Faber, A; Hoedt, S; Hofheinz, RD; Hörmann, K; Sauter, A; Schultz, JD; Sommer, JU; Thorn, C | 1 |
| Erben, P; Faber, A; Hoedt, S; Hoermann, K; Hofheinz, RD; Sauter, A; Schultz, DJ; Sommer, U; Stern-Straeter, J | 1 |
| Ammer, AG; Hayes, KE; Kelley, LC; Martin, KH; Walk, EL; Weed, SA | 1 |
| Donato, NJ; Johnson, FM; Newman, RA; Yang, P | 1 |
| Donato, NJ; Johnson, FM; Saigal, B | 1 |
| Hirase, C; Kanamaru, A; Maeda, Y; Matsuda, M; Miyatake, J; Morita, Y; Shimada, T; Tanaka, M; Tatsumi, Y | 1 |
| Bruce, IA; Homer, JJ; McGown, AT; Slevin, NJ; Ward, TH | 1 |
| Hong, RL; Hsu, C; Jeng, YM; Lin, CH; Tzen, CY; Yen, RF | 1 |
| Aguilera, J; An, Y; Chu, TS; Dang, CL; Ongkeko, WM; Wang-Rodriguez, J | 1 |
| Altuna, X; Chu, TS; Lopez, JP; Ongkeko, WM; Wang-Rodriguez, J; Weisman, RA | 1 |
| Awada, A; De Saint Aubain, N; Flamen, P; Gil, T; Kasper, B; Lossignol, D | 1 |
| Petersen, JE; Wright, TI | 1 |
| Azim, HA; Elsedewy, E | 1 |
| Kutner, A; Milczarek, M; Wietrzyk, J | 1 |
3 review(s) available for imatinib mesylate and Cancer of Head
| Article | Year |
|---|---|
Chordoma: A Case Report and Review of Literature.
Topics: Afatinib; Aged; Antineoplastic Agents; Chordoma; Combined Modality Therapy; Female; Head and Neck Neoplasms; Hoarseness; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Spinal Neoplasms | 2020 |
The role of targeted molecular inhibitors in the management of advanced nonmelanoma skin cancer.
Topics: Anilides; Antineoplastic Agents; Benzamides; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatofibrosarcoma; ErbB Receptors; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Molecular Targeted Therapy; Neoplasms, Squamous Cell; Piperazines; Pyridines; Pyrimidines; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2011 |
Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Cisplatin; Dendritic Cells, Follicular; Deoxycytidine; Follow-Up Studies; Gemcitabine; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Piperazines; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
3 trial(s) available for imatinib mesylate and Cancer of Head
| Article | Year |
|---|---|
Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).
Topics: Abdominal Neoplasms; Abdominal Wall; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Extremities; Female; Fibromatosis, Aggressive; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Pyrimidines; Response Evaluation Criteria in Solid Tumors; Retroperitoneal Neoplasms; Soft Tissue Neoplasms; Thoracic Neoplasms; Thoracic Wall; Treatment Outcome; Young Adult | 2017 |
Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Becaplermin; Benzamides; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chi-Square Distribution; Disease-Free Survival; Docetaxel; Early Termination of Clinical Trials; Female; Gene Dosage; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Piperazines; Proportional Hazards Models; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Taxoids | 2011 |
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Benzamides; Carcinoma, Adenoid Cystic; Disease Progression; DNA Mutational Analysis; Female; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Lung Neoplasms; Male; Middle Aged; Pilot Projects; Piperazines; Pleural Effusion, Malignant; Protein-Tyrosine Kinases; Pyrimidines | 2005 |
21 other study(ies) available for imatinib mesylate and Cancer of Head
| Article | Year |
|---|---|
Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
Topics: Adult; Aged; Antineoplastic Agents; Cell Transformation, Neoplastic; Dermatofibrosarcoma; Disease-Free Survival; Extremities; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Lung Neoplasms; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Soft Tissue Neoplasms; Torso; Treatment Outcome; Young Adult | 2017 |
Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin.
Topics: Carcinoma, Squamous Cell; Cell Adhesion; Cell Line, Tumor; Combined Modality Therapy; DNA Breaks, Double-Stranded; Head and Neck Neoplasms; HeLa Cells; Humans; Imatinib Mesylate; Immunoglobulin G; Integrin beta1; MCF-7 Cells; Molecular Targeted Therapy; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Radiation Tolerance; Squamous Cell Carcinoma of Head and Neck | 2017 |
Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.
Topics: Animals; Antineoplastic Agents; Cell Line; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Mice, Inbred NOD; Mice, SCID; MicroRNAs; Neural Stem Cells; Organogenesis; Paraganglioma; Primary Cell Culture; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Topics: Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Fluorouracil; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinases; Papillomavirus Infections; Piperazines; Pyrimidines | 2014 |
Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Immunoprecipitation; Neoplasm Proteins; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines | 2008 |
The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Topics: Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Enzyme-Linked Immunosorbent Assay; Female; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neovascularization, Pathologic; Piperazines; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2009 |
Synergistic effects of imatinib and carboplatin on VEGF, PDGF and PDGF-Rα/ß expression in squamous cell carcinoma of the head and neck in vitro.
Topics: Antineoplastic Agents; Benzamides; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Transcription, Genetic; Vascular Endothelial Growth Factor A | 2011 |
Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCC.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carboplatin; Carcinoma, Squamous Cell; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Matrix Metalloproteinase 2; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Tumor Cells, Cultured | 2011 |
Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Topics: Adult; Angiogenic Proteins; Antineoplastic Agents; Benzamides; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Viral; Female; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Middle Aged; Papillomavirus Infections; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Vascular Endothelial Growth Factor A | 2011 |
Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Topics: Antineoplastic Agents; Benzamides; beta Catenin; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Immunohistochemistry; In Vitro Techniques; Papillomavirus Infections; Piperazines; Pyrimidines; Signal Transduction; Stem Cell Factor; Viral Core Proteins | 2012 |
Alteration of MMP-2 and -14 expression by imatinib in HPV-positive and -negative squamous cell carcinoma.
Topics: Antineoplastic Agents; Benzamides; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Gene Expression; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Imatinib Mesylate; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Papillomavirus Infections; Piperazines; Pyrimidines | 2012 |
Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop.
Topics: Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Extracellular Matrix; Head and Neck Neoplasms; Heparin-binding EGF-like Growth Factor; Humans; Imatinib Mesylate; Intercellular Signaling Peptides and Proteins; Neoplasm Invasiveness; Piperazines; Protein Kinases; Pyrimidines; src-Family Kinases | 2013 |
Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate.
Topics: Anti-Infective Agents, Local; Antineoplastic Agents; Arachidonic Acid; Benzamides; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Activation; ErbB Receptors; Gentian Violet; Head and Neck Neoplasms; Humans; Imatinib Mesylate; MAP Kinase Kinase 1; Membrane Proteins; Piperazines; Prostaglandin-Endoperoxide Synthases; Pyrimidines; Time Factors | 2004 |
Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
Topics: Antineoplastic Agents; Benzamides; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Head and Neck Neoplasms; Heparin-binding EGF-like Growth Factor; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Intercellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Stem Cell Factor | 2005 |
Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate.
Topics: Adolescent; Antineoplastic Agents; Benzamides; Blast Crisis; Central Nervous System Neoplasms; Clone Cells; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pyrimidines | 2005 |
Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Cell Line, Tumor; Comet Assay; Drug Antagonism; Drug Synergism; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2005 |
Gleevec suppresses p63 expression in head and neck squamous cell carcinoma despite p63 activation by DNA-damaging agents.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Damage; Down-Regulation; Gene Expression; Genes, abl; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Immunohistochemistry; Membrane Proteins; Piperazines; Pyrimidines | 2006 |
STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Drug Synergism; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Mitosis; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor | 2006 |
Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.
Topics: Antineoplastic Agents; Benzamides; Dermatofibrosarcoma; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Metastasis; Piperazines; Positron-Emission Tomography; Pyrimidines; Scalp; Skin Neoplasms; Tomography, X-Ray Computed | 2006 |
Treatment of recurrent dermatofibrosarcoma protuberans with imatinib mesylate, followed by Mohs micrographic surgery.
Topics: Adult; Antineoplastic Agents; Benzamides; Dermatofibrosarcoma; Female; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Mohs Surgery; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Scalp; Skin Neoplasms | 2007 |
The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Calcitriol; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cisplatin; Dihydroxycholecalciferols; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Ergocalciferols; G1 Phase; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Piperazines; Pyrimidines; Resting Phase, Cell Cycle; Taxoids | 2007 |